1,408
Views
50
CrossRef citations to date
0
Altmetric
Research Article

Solid Lipid Nanoparticles Containing Tamoxifen Characterization and In Vitro Antitumoral Activity

, , , &
Pages 385-392 | Received 20 Jun 2004, Accepted 26 Aug 2004, Published online: 10 Oct 2008

Figures & data

TABLE 1 Dimensional analysis by PCS and drug-loading capacity of tamoxifen-loaded SLN prepared by warm oil-in-water microemulsion (SLN-m) and by precipitation method (SLN-p)

TABLE 2 Zeta potential values (mV) of the tamoxifen-loaded SLN prepared by warm oil-in-water microemulsion (SLN-m) and by precipitation method (SLN-p)

FIG. 1 Tamoxifen stability at 37°C in human plasma. Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 1 Tamoxifen stability at 37°C in human plasma. Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 2 Release profiles of tamoxifen at pH 7.4 and in plasma from nanoparticles prepared by precipitation technique (SLN-p). Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 2 Release profiles of tamoxifen at pH 7.4 and in plasma from nanoparticles prepared by precipitation technique (SLN-p). Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 3 Release profile of tamoxifen at pH 1.1 from nanoparticles prepared by precipitation technique (SLN-p). Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 3 Release profile of tamoxifen at pH 1.1 from nanoparticles prepared by precipitation technique (SLN-p). Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 4 Amount of tamoxifen entrapped in the SLN prepared by precipitation technique (SLN-p) as function of release time at pH 1.1. Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 4 Amount of tamoxifen entrapped in the SLN prepared by precipitation technique (SLN-p) as function of release time at pH 1.1. Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 5 Release profile of tamoxifen into octanol phase from nanoparticles prepared by precipitation technique (SLN-p). Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 5 Release profile of tamoxifen into octanol phase from nanoparticles prepared by precipitation technique (SLN-p). Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 6 Antiproliferative activity of free tamoxifen and tamoxifen-loaded SLN, prepared by precipitation technique (SLN-p), on human breast cancer MCF-7 cells. Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

FIG. 6 Antiproliferative activity of free tamoxifen and tamoxifen-loaded SLN, prepared by precipitation technique (SLN-p), on human breast cancer MCF-7 cells. Each value is the mean of three experiments. All calculated SE were less than 3% of the mean values and then they were not reported.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.